Invivoscribe, Inc., is a network of eight wholly-owned companies located in regional hubs in five countries. We offer IVD and companion diagnostic test development, submission, and commercialization activities and support worldwide clinical trials, offer chromosome translocation, gene mutation reagents, pharmaceutical agents and device testing, OEM reagents, and assays. We sell products directly and through distributor channels into more than 700 clinical laboratories located in over 160 countries.